Abstract:Background: Renal dysfunction after kidney transplantation may be influenced by many reasons. This study was designed to evaluate whether the administration of dexmedetomidine (Dex) could ameliorate renal function and prognosis after kidney transplantation. Methods: A total of 65 patients were divided into Dex group (n = 33) and Con group (Con, n = 32). Dex group intravenously received an initial loading dose of 0.6 μg/kg Dex for 15 min before anaesthesia induction, followed by a rate of 0.4 μg/kg/h until 30 min after kidney reperfusion. By contrast, Con group received saline. The concentration of urinary kidney injury molecule-1 (KIM-1), serum creatinine (Cr), blood urea, urine output, β2 microglobulin (β2-MG), Cystatin C (CysC), and estimated glomerular filtration rate (eGFR) was recorded and compared between two groups during the course of the hospitalization or follow-up. Mean arterial pressure (MAP) and heart rate (HR), vasoactive drugs, and anaesthetics were recorded during the operation. Pain degree was evaluated using a visual analogue scale (VAS) after operation. Delayed graft function (DGF), graft loss, length of hospital stay, and mortality were compared between groups. Results: The concentration of KIM-1 in Dex group was lower than Con group at 2 h (P = 0.018), 24 h (P = 0.013), 48 h (P < 0.01), and 72 h (P < 0.01) after reperfusion. MAP of Dex group after tracheal intubation (P = 0.012) and incision (P = 0.018) and HR after intubation (P = 0.021) were lower than that of Con group. The dosage of sufentanil during operation in Dex group was less than Con group (P = 0.039). Patients that used atropine in Dex group were more than Con group (P = 0.027). Patients who received Dex presented with lower VAS scores at 6 h (P = 0.01) and 12 h (P = 0.002) after operation. Concentration of serum Cr and blood urea had no significant differences between groups before operation and on postoperative day 1 to 6. Urine output was recorded for 6 days after operation and had no differences between groups. Also, no differences were identified between two groups in urea, Cr, β2-MG, CysC, and eGFR in the first 3 months after operation. Incidence of DGF after operation was detected no difference between groups, while length of hospital stay in Dex group was less than Con group (P = 0.012). Conclusion: Dex can decrease kidney injury marker level, attenuate perioperative stress, relieve the dosage of sufentanil and postoperative pain, and reduce length of hospital stay. However, Dex is not associated with changes in prognosis in the first 3 months after transplantation.

The effect of the concurrent use of Dexmedetomidine (DEX) during the perioperative period on the renal function of patients following craniocerebral interventional surgery

Effect of Dexmedetomidine on Prognosis after Cardiac Surgery with Cardiopulmonary Bypass

The effect of dexmedetomidine on the postoperative recovery of patients with severe traumatic brain injury undergoing craniotomy treatment: a retrospective study

Affection of Dexmedetomdine on Perioperative Patients with Intracranial Aneurysm Administration in Interventional Treatment

Effects of Supplemental Dexmedetomidine Anesthesia on Intracranial Aneurysm Patients Undergoing Intracranial Interventional Embolization

Correlation between perioperative dexmedetomidine administration and postoperative acute kidney injury in hypertensive patients undergoing non-cardiac surgery

Renoprotective Effect of Intraoperative Dexmedetomidine in Renal Transplantation

Intraoperative dexmedetomidine use is associated with lower incidence of acute kidney injury after non-cardiac surgery

Effects of low-dose dexmedetomidine on postoperative delirium incidence in the elderly with a history of cerebral stroke：a secondary analysis based on a random clinical trial

Impact Of Dexmedetomidine On The Incidence Of Delirium In Elderly Patients After Cardiac Surgery: A Randomized Controlled Trial

Dexmedetomidine and acute kidney injury after non-cardiac surgery: a meta-analysis with trial sequential analysis

Dexmedetomidine Mitigates Acute Kidney Injury after Coronary Artery Bypass Grafting: a Prospective Clinical Trial.

Effects of dexmedetomidine on postoperative cognitive function in patients undergoing coronary artery bypass grafting

The effect of dexmedetomidine on the incidence of postoperative delirium in critically ill elderly patients

Effects of dexmedetomidine on emergence delirium and electroencephalogram during the recovery period in older patients undergoing lower limb orthopedic surgery: A randomized, double-blind, placebo-controlled clinical trial

Effects of Dexmedetomidine on Cardioprotection and Other Postoperative Complications in Elderly Patients after Cardiac and Non-Cardiac Surgerie

[Preventive Effect of Dexmedetomidine on Postoperative Delirium in Elderly Patients with Oral Cancer].

Effects of Dexmedetomidine As an Adjuvant to General Anesthesia on Perioperative Hemodynamic Reaction in Pediatric Patients Undergoing Craniotomy: a Pilot Study

[Effects of Dexmedetomidine on Perioperative Cardiac Adverse Events in Elderly Patients with Coronary Heart Disease].

Effect Evaluation of Dexmedetomidine Intravenous Anesthesia on Postoperative Agitation in Patients with Craniocerebral Injury by Magnetic Resonance Imaging Based on Sparse Reconstruction Algorithm

Effects of dexmedetomidine on renal function after cardiac surgery for infective endocarditis: An interim analysis of a randomized controlled trial